Browsing SPH Scholarly Articles by Author "Dirajlal-Fargo, Sahera"
Now showing items 1-1 of 1
-
Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
Dirajlal-Fargo, Sahera; Moser, Carlee; Brown, Todd T.; Kelesidis, Theodoros; Dube, Michael P.; Stein, James H.; Currier, Judith; McComsey, Grace A. (Oxford University Press, 2016)Background. Antiretroviral therapy (ART) can alter glucose metabolism, but little data exist on the association of raltegravir (RAL) with insulin resistance. Methods. A5260s was a substudy of A5257, a prospective open-label ...